Collectively, the frequencies of blood Th17 cells, based on IL-17 (% of CD4+), in MASLD patients were significantly increased compared with the HCs group (p<0.05), while Treg cell population prevalence was decreased (Table 2). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.